At Krystal Biotech, Inc., our mission is to make a meaningful difference in the lives of underserved patient populations suffering from debilitating skin diseases. We work to accomplish this goal through scientific innovation and operational excellence, believing that "nature operates in the shortest way possible" (Aristotle). We are a clinical-stage gene therapy company using our proprietary, engineered virus vector platform to develop effective and innovative treatments for skin diseases. While we are initially developing topical and intradermal "off-the-shelf" novel therapies for rare and orphan dermatological indications, we are expanding the use of our pioneering gene technology to target and treat other rare diseases. The diseases for which we develop therapies provide inspiration for our day-to-day activities. There is clarity in purpose, a collective empathy driving us forward. Krystal was named after this clarity — a simple realization that we can do better. In doing so, we extend gratitude to the patients, caregivers, advocates and physicians dedicated to the diseases which unite us in purpose. Community Guidelines: http://bit.ly/KrystalCG